Literature DB >> 21220377

Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases?

J Linn1, G Fesl, C Ottomeyer, A Straube, M Dichgans, H Bruckmann, T Pfefferkorn.   

Abstract

INTRODUCTION: Differential diagnoses of the reversible cerebral vasoconstriction syndrome (RCVS) include all forms of intracranial stenotic disease, such as primary or secondary vasculitis of the central nervous system. Here, we tested the hypothesis that angiographic response to intra-arterial nimodipine application may be helpful in differentiating between RCVS and other entities.
METHODS: A digital subtraction angiographic (DSA) series of nine consecutive patients with suspected RCVS that were treated by intra-arterial nimodipine due to clinical worsening were retrospectively analyzed. Pre- and post-therapeutic DSA findings of patients with later-confirmed RCVS were compared to those in which another diagnosis was finally made.
RESULTS: Intra-arterial nimodipine resulted in a normalization of both the diameter of the main trunks of the cerebral vessels and the caliber of the peripheral vessels in all RCVS patients. This was not the case in the non-RCVS patients, in whom only a slight general vasodilatation was observed. DISCUSSION: Our preliminary results indicate that angiographic response to intra-arterial application might be a helpful differential diagnostic tool in select patients with suspected RCVS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220377     DOI: 10.1177/0333102410394673

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  18 in total

1.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

2.  Headache and visual impairment after twin birth: a challenging diagnosis.

Authors:  Alberto Fortini; Massimo Cincotta; Antonio Faraone; Cristina Baruffi; Giovanni Carrieri; Nicola Limbucci; Costanza Boccadori; Gabriele Nenci
Journal:  Intern Emerg Med       Date:  2017-07-14       Impact factor: 3.397

Review 3.  [Neuroimaging of cerebral vasculitis].

Authors:  M Wengenroth; T Saam; S Hähnel
Journal:  Radiologe       Date:  2016-01       Impact factor: 0.635

Review 4.  Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls.

Authors:  P Berlit; M Kraemer
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

5.  Reversible cerebral vasoconstriction syndromes: what the cardiologist should know.

Authors:  Aneesh B Singhal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

6.  Severe reversible cerebral vasoconstriction syndrome in a postpartum patient treated successfully with direct instillation of intra-arterial verapamil during cerebral angiography.

Authors:  M T Crockett; M Di Loreto; T J Philips
Journal:  J Vasc Interv Neurol       Date:  2017-12

Review 7.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

8.  Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

9.  Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.

Authors:  F Seker; J Hesser; M A Brockmann; E Neumaier-Probst; C Groden; R Schubert; C Brockmann
Journal:  Clin Neuroradiol       Date:  2015-09-08       Impact factor: 3.649

10.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.